RM2E10KCW–Kolkata, India. 03rd Jan, 2021. (1/3/2021) A boy standing in front a wall graffiti which tell about Front line warriors and the Vaccination in Kolkata. India added 18,177 coronavirus infections in the past 24 hours. India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. (Photo by Sudipta Das/Pacific Press/Sipa USA) Credit: Sipa USA/Alamy Live News
RM2E10KBE–Kolkata, India. 03rd Jan, 2021. (1/3/2021) A woman is passing through in front of a wall graffiti which tell about Front line warriors and the Vaccination in Kolkata. India added 18,177 coronavirus infections in the past 24 hours. India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. (Photo by Sudipta Das/Pacific Press/Sipa USA) Credit: Sipa USA/Alamy Live News
RM2E10KB2–Kolkata, India. 03rd Jan, 2021. (1/3/2021) A man is passing through in front of a wall graffiti which tell about Front line warriors and the Vaccination in Kolkata. India added 18,177 coronavirus infections in the past 24 hours. India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. (Photo by Sudipta Das/Pacific Press/Sipa USA) Credit: Sipa USA/Alamy Live News
Download Confirmation
Please complete the form below. The information provided will be included in your download confirmation